tradingkey.logo

InfuSystem Holdings Inc

INFU
查看詳細走勢圖
9.160USD
-0.040-0.43%
收盤 12/22, 16:00美東報價延遲15分鐘
186.20M總市值
34.59本益比TTM

InfuSystem Holdings Inc

9.160
-0.040-0.43%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.43%

5天

-0.87%

1月

-3.17%

6月

+46.56%

今年開始到現在

+8.40%

1年

+10.23%

查看詳細走勢圖

TradingKey InfuSystem Holdings Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

InfuSystem Holdings Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名60/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價14.20。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

InfuSystem Holdings Inc評分

相關信息

行業排名
60 / 208
全市場排名
155 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 5 分析師
買入
評級
14.200
目標均價
+62.29%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

InfuSystem Holdings Inc亮點

亮點風險
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
業績高增長
公司營業收入穩步增長,連續3年增長22.70%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入134.86M美元
估值低估
公司最新PE估值34.74,處於3年歷史低位
機構減倉
最新機構持股15.39M股,環比減少14.67%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉976.18K股
活躍度增加
近期活躍度增加,過去20天平均換手率2.54

InfuSystem Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

InfuSystem Holdings Inc簡介

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
公司代碼INFU
公司InfuSystem Holdings Inc
CEOLachance (Carrie A)
網址https://ir.infusystem.com/

常見問題

InfuSystem Holdings Inc(INFU)的當前股價是多少?

InfuSystem Holdings Inc(INFU)的當前股價是 9.160。

InfuSystem Holdings Inc 的股票代碼是什麼?

InfuSystem Holdings Inc的股票代碼是INFU。

InfuSystem Holdings Inc股票的52週最高點是多少?

InfuSystem Holdings Inc股票的52週最高點是11.040。

InfuSystem Holdings Inc股票的52週最低點是多少?

InfuSystem Holdings Inc股票的52週最低點是4.610。

InfuSystem Holdings Inc的市值是多少?

InfuSystem Holdings Inc的市值是186.20M。

InfuSystem Holdings Inc的淨利潤是多少?

InfuSystem Holdings Inc的淨利潤為2.35M。

現在InfuSystem Holdings Inc(INFU)的股票是買入、持有還是賣出?

根據分析師評級,InfuSystem Holdings Inc(INFU)的總體評級為買入,目標價格為14.200。

InfuSystem Holdings Inc(INFU)股票的每股收益(EPS TTM)是多少

InfuSystem Holdings Inc(INFU)股票的每股收益(EPS TTM)是0.265。
KeyAI